Market Overview

Morgan Stanley Sees Growth Platforms Building for Stericycle

Related SRCL
Waste Management (WM) Beats on Q2 Earnings, Revenues Up Y/Y
Credit Suisse Believes Top Line Growth Matters More Than Margins For Stericycle

In a report published Thursday, Morgan Stanley analyst David R. Lewis reiterated an Equal-Weight rating on Stericycle (NASDAQ: SRCL).

In the report, Morgan Stanley noted, “Organic revenue growth in 4Q13 ticked up slightly versus 3Q13 but remains consistent with 2012-13 trends. Greater traction from StrongPak is a modest positive but drove margin dilution. Full valuation and limited visibility on sustainable growth acceleration keeps us from a more constructive view.”

Stericycle closed on Wednesday at $116.48.

Posted-In: David R. Lewis Morgan StanleyAnalyst Color Reiteration Analyst Ratings

 

Most Popular

Related Articles (SRCL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters